NCT04557319View on ClinicalTrials.gov

Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

March 10, 2020

Primary Completion Date

August 27, 2020

Study Completion Date

August 27, 2020

Conditions
Hereditary Angioedema
Interventions
BIOLOGICAL

GNR-038, 25 МЕ/kg

25 МЕ/kg once per study

BIOLOGICAL

GNR-038, 50 МЕ/kg

50 МЕ/kg once per study

BIOLOGICAL

GNR-038, 100 МЕ/kg

100 МЕ/kg once per study

Trial Locations (1)

117556

"State budgetary institution of healthcare of the city of Moscow Сity polyclinic No. 2 of the Department of healthcare of the city of Moscow", Moscow

All Listed Sponsors
lead

AO GENERIUM

INDUSTRY

NCT04557319 - Safety and Pharmacokinetics of GNR-038 in Healthy Volunteers | Biotech Hunter | Biotech Hunter